Certain individuals, particularly those with a personal or familial history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2, should not opt for semaglutide treatment
Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II
Patients experiencing major GI bleeding may be at risk of life-threatening complications, including shock, anaemia, or even death
Did it begin shortly after starting semaglutide, or did it worsen over time
The speed of this process is striking
Clinical Considerations Healthcare providers often take a cautious approach when prescribing semaglutide, especially at higher doses, for patients with a history of GERD